Homoeopathic management of Type II Diabetes mellitus

Practical Application of Susceptibility by using Jahr’s Criteria in management of Type II Diabetes Mellitus: A Clinical Observational Study - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/05/067608

Enrollment

Registered

2024-05-20

Start date

Unknown

Completion date

Unknown

Last updated

2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: Individualised Homoeopathic Medicine: Medicine will be dispensed in 6c,30c ,200c,1m potency and follow up is in 15 days interval Control Intervention1: NIL: Not Applicable

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients willing to take Homoeopathic Medicine. 2. Patients exhibiting sign & symptom or, both that are indicative of Type – II Diabetes Mellitus. 3. Patients having Fasting blood sugar (FBS) level between 125 - 140 mg/dl. 4. Patients having Post prandial blood sugar (PPBS) level between 200-240 mg /dl. 5. Patients having age group between 30 -70 yrs. 6. Patients of both sexes. 7. Patients who have already had other method of treatment but now intend to undergo homoeopathic treatment, after providing a gap of six week as a wash out period.

Exclusion criteria

Exclusion criteria: 1. Patients suffering from Type –I Diabetes Mellitus. 2. Patients who are not willing to participate in the study. 3. Patients with vital organ failure or any other life-threatening systemic diseases. 4. Psychiatric patients. 5. Cases with gross pathological changes. 6. Pregnant and lactating women.

Design outcomes

Primary

Measure	Time frame
response of the patients will be assessed by FBS, PPBS at baselineTimepoint: 1 months-3 months	—

Secondary

Measure	Time frame
The response of the patient will be assessed by DSC – R for Quality of Life at baseline and 3 months after treatment.Timepoint: 3 month	—

Countries

India

Contacts

Public ContactDr Surendra Kumar Shrivastava

R.B.T.S. Govt. Homoeopathic Medical College & Hospital

drsurendrarbts@gmail.com9470468526

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026